geraniol has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laschke, MW; Menger, MD; Parakenings, J; Scheuer, C; Wittig, C | 1 |
| Manoharan, S; Nirmal, MR; Sindhu, G; Vetrichelvi, V; Vinothkumar, V | 1 |
2 other study(ies) available for geraniol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Geraniol Suppresses Angiogenesis by Downregulating Vascular Endothelial Growth Factor (VEGF)/VEGFR-2 Signaling.
Topics: Acyclic Monoterpenes; Animals; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Hemodynamics; Humans; Immunohistochemistry; In Vitro Techniques; Male; Mice, Inbred BALB C; Microvessels; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Rats, Sprague-Dawley; Signal Transduction; Stress Fibers; Terpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Geraniol modulates cell proliferation, apoptosis, inflammation, and angiogenesis during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acyclic Monoterpenes; Animals; Apoptosis; Biomarkers, Tumor; Carcinogens; Carcinoma, Squamous Cell; Cell Proliferation; Cell Transformation, Neoplastic; Cricetinae; Inflammation; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Terpenes | 2012 |